We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCT icon
7076
Nuvectis Pharma
NVCT
$632M
$2.26K ﹤0.01%
301
+100
+50% +$716
ALGS icon
7077
Aligos Therapeutics
ALGS
$45.5M
$2.24K ﹤0.01%
94
-317
-77% -$7.99K
CLPS icon
7078
CLPS Inc
CLPS
$26M
$2.24K ﹤0.01%
2,000
INUV icon
7079
Inuvo
INUV
$17M
$2.24K ﹤0.01%
1,011
LPTH icon
7080
Lightpath Technologies
LPTH
$822M
$2.22K ﹤0.01%
1,820
SINT icon
7081
SiNtx Technologies
SINT
$11.3M
$2.22K ﹤0.01%
1
AHI
7082
DELISTED
Advanced Health Intelligence Ltd
AHI
$2.21K ﹤0.01%
1,350
-1,127
-45% -$1.96K
CMND icon
7083
Clearmind Medicine
CMND
$2.39M
0
FXNC icon
7084
First National Corp
FXNC
$290M
$2.21K ﹤0.01%
129
-1,837
-93% -$31.1K
CEPU
7085
Central Puerto
CEPU
$2B
$2.2K ﹤0.01%
370
-102
-22% -$502
CWBR
7086
DELISTED
CohBar, Inc. Common Stock
CWBR
$2.18K ﹤0.01%
1,288
+16
+1% +$33
BIOL
7087
DELISTED
Biolase, Inc.
BIOL
$2.16K ﹤0.01%
33
-51
-61% -$7.34K
CYCN icon
7088
Cyclerion Therapeutics
CYCN
$16.7M
$2.16K ﹤0.01%
164
-6
-4% -$71
STRR
7089
DELISTED
Star Equity Holdings
STRR
$2.14K ﹤0.01%
500
ANY icon
7090
Sphere 3D
ANY
$18.7M
$2.13K ﹤0.01%
111
-15
-12% -$391
QBTS icon
7091
D-Wave Quantum Inc. Common Stock
QBTS
$7.53B
$2.13K ﹤0.01%
1,482
+1,167
+370% +$4.12K
HARP
7092
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.13K ﹤0.01%
294
-1,102
-79% -$9.28K
ONCR
7093
DELISTED
Oncorus, Inc.
ONCR
$2.13K ﹤0.01%
8,394
-6,995
-45% -$3.98K
CHCI icon
7094
Comstock Holding Companies
CHCI
$153M
$2.13K ﹤0.01%
500
UBOT icon
7095
Direxion Daily Robotics Artificial Intelligence & Automation Index Bull 2X ETF
UBOT
$26.7M
$2.12K ﹤0.01%
176
BTCR
7096
DELISTED
Volt Crypto Industry and Equity ETF
BTCR
$2.11K ﹤0.01%
447
DEED icon
7097
First Trust Securitized Plus ETF
DEED
$64.4M
$2.11K ﹤0.01%
100
BIS icon
7098
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.06M
$2.1K ﹤0.01%
54
NIXX
7099
Nixxy Inc
NIXX
$15.9M
$2.1K ﹤0.01%
334
-133
-28% -$1.16K
BCDA icon
7100
BioCardia
BCDA
$13.9M
$2.05K ﹤0.01%
66

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.